Macquarie Maintains Outperform on Imax, Raises Price Target to $48

IMAX Corporation

IMAX Corporation

IMAX

0.00

Macquarie analyst Chad Beynon maintains Imax (NYSE: IMAX) with a Outperform and raises the price target from $46 to $48.